[Pathogenetic basis for using proteinase inhibitors in the combined treatment of rosacea].
D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007610:Kallikreins / Q000097:blood; D007705:Kinins / Q000097:blood; D008297:Male; D011480:Protease Inhibitors / Q000627:therapeutic use*; D012393:Rosacea / Q000097:blood / Q000188:drug therapy* / Q000209:etiology
D007705:Kinins; D011480:Protease Inhibitors; D007610:Kallikreins
Patogeneticheskoe obosnovanie primeneniia ingibitorov proteinaz v kompleksnom lechenii rozatsea.